Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.

By R. Soetikno, O. Lin, P. Heidenreich, H. Young, M. Blackstone. Gastrointestinal Endoscopy, 2002

624 citations recorded by the source corpus.

Subfields: Genetics, Hepatology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/1fccf65addae8c6c2a86578548679164af75102d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Karlsen
2. U. Beuers
3. T. Folseraas
4. D. Thorburn
5. M. Vesterhus
6. P. Invernizzi
7. M. Trauner
8. K. Boberg

Citations in the corpus

• EASL Clinical Practice Guidelines: management of cholestatic liver diseases. (2009, positive): “A diagnosis of IBD has implications for follow-up and dysplasia/ cancer surveillance as patients with UC and PSC have a higher risk of dysplasia and colon cancer than patients with UC only [101,102].”
• Primary sclerosing cholangitis - a comprehensive review. (2017, background): “be performed regularly from the diagnosis of PSC as elaborated below (56-59).”